Objective: Application of therapeutic mild hypothermia in patients after resuscitation, often accompanied by myocardial infarction, cardiogenic shock, and systemic inflammation may impact on cardiac rhythm. We therefore tested susceptibility to atrial arrhythmias during hyperthermia (HT, 40.5 • C), normothermia (NT, 38.0 • C), and mild hypothermia (MH, 33.0 • C).
INTRODUCTION
Mild hypothermia (MH, 32-34 • C) is an established therapy after cardiac arrest, 1 impacting positively on survival as well as on neurologic outcome. 2, 3 However, after publication of the TTM trial in 2013, the optimal target temperature for resuscitated patients remains unclear. 4 MH reduces systemic metabolism and may preserve systemic oxygen supply-demand balance during cardiogenic shock and septic cardiomyopathy.
There have been single observations of atrial and ventricular tachyarrhythmias during therapeutic MH, but data available on potential proarrhythmic effects of MH are not conclusive. 3, 5, 6 Since the main goal of MH is to improve neurological outcomes after cardiac arrest, not much focus has been set on arrhythmias yet. However, as most resuscitated patients are cardiac patients, possible arrhythmogenic effects of MH are highly relevant.
Clinical trials have shown contradicting results on the arrhythmogenicity of MH. Some studies showed no clinically significant arrhythmias at temperatures between 33 • C and 36 • C, 7, 8 while others showed an increased prevalence of adverse events including arrhythmias. [9] [10] [11] A post hoc analysis of the TTM trial showed a prevalence of 11% and 15% of atrial fibrillation (AF) in patients cooled to 36 • C and 33 • C, which was independently associated with higher mortality. 12 Incidence of arrhythmias during therapeutic hypothermia has been reported in multiple clinical settings. Out of 12 patients included in the COOL Shock Study, one developed AF at the target temperature of 33 • C which could be terminated by rewarming the patient. 5 Cooling had to be aborted due to arrhythmias resulting in hemodynamic instability in three out of the 137 patients enrolled in the hypothermia group in the initial report proposing therapeutic hypothermia to improve neurologic outcome after cardiac arrest. 3 As for MH, proarrhythmic effect of hyperthermia (HT) remains incompletely understood. While HT has been shown to prevent structural remodeling favoring AF in preclinical studies, acute effects on atrial arrhythmogenicity remain unknown. 13, 14 While most of the available studies have been performed on isolated cardiomyocytes or muscle strips, an in vivo study on susceptibility to atrial tachyarrhythmias has not been performed so far. We therefore performed repeated measurements at HT (40. 
MATERIALS AND METHODS
The experimental protocol was approved by the local bioethics com- 
Experimental setup
The experimental setup has been described before. 15, 16 Briefly, landrace pigs (n = 10, 67 ± 2 kg) were fasted overnight with free access to water and sedated with 0.5 mg/kg midazolam and 20 mg/kg ketamine.
After administration of 1 mg/kg propofol, the animals were intubated, and anesthesia was continued with 1% sevoflurane, 35 g/kg/h fentanyl, 1.25 mg/kg/h midazolam, 0.2 mg/kg/h pancuronium, and 3 mg/kg/h ketamine. The animals were ventilated ("Julian," Draeger, • C and subsequently to 33 • C by internal cooling using the cooling device. Right atrial pacing was performed using an external stimulator (UHS20, Biotronik, Berlin, Germany). A balanced crystalloid infusion (Elo-Mel Isoton, Fresenius, Graz, Austria) was continuously administered at a fixed rate of 10 mL/kg/h. Urine outflow was enabled by a suprapubic catheter. Figure 1 illustrates the temperature protocol.
Electrophysiologic study
Effective atrial refractory period (AERP) was determined by a S1-S2 stimulation protocol (1-ms pulse at twice diastolic threshold at cycle lengths of 400, 350, 300, 250, and 200 ms). In detail, the AERP was determined using a train of 10 basic stimuli (S1) followed by one premature stimulus (S2). The premature stimulus was delivered in decrements of 10 ms until capture was lost. The procedure was then repeated in 2-ms decrements within the final 10-ms window. AERP was defined as the longest S1-S2 interval failing a propagated response.
Inducibility of AF was assessed by burst protocols (1-ms pulse at four times diastolic threshold, cycle length 50 ms, 10-second F I G U R E 1 Study protocol outlining EP time points during HT, NT, and MH. EP study: measurement of surface ECG parameters, atrial effective refractory periods, and AF inducibility. AF = atrial fibrillation; ECG = electrocardiogram; EP = electrophysiology; HT = hyperthermia; MH = mild hypothermia; NT = normothermia duration, five repetitions, with 10-second pause between bursts). An AF episode was defined as the onset of irregular atrial electrograms with an average cycle length shorter than 200 ms ≥ 10 seconds duration.
Measurements were started at 40.5 • C (HT) and repeated at 38.0 • C (NT) and 33.0 • C (MH). Note that 38 • C was chosen as a reference, since this is a pig's normal core body temperature. Animals were again allowed to stabilize for 45 minutes at each temperature step before measurements were repeated.
Body surface 12-lead electrocardiograms were recorded at every temperature step at spontaneous and paced heart rates, digitized at 1 kHz to 16-bit resolution using CardioLab (GE Healthcare) and used for offline analysis. Offline analysis included measurements of PQ intervals during spontaneous heart rates, Stim-Q intervals during pacing (interval between the stimulation artifact and the beginning of the Q wave), as well as QRS duration, QT duration, and time from peak to end of the t-wave (TpTe). TpTe interval was manually measured from leads V4 to V6. The peak of the t-wave was defined as the point with the highest amplitude of the T-wave deflection, while the end was defined as the point of intersection of the descending limb's tangent and the isoelectric line. 17, 18 QTc was calculated using the Hodges formula (QTc = QT + 1.75 (HR-60)). 19 
Blood samples
At each step of the experimental protocol, arterial blood samples were processed immediately after withdrawal using a blood gas analyzer (ABL 600; Radiometer, Copenhagen, Denmark) equipped for the temperature-corrected measurement of electrolytes, oxygen saturation, partial oxygen and carbon dioxide pressures, pH, acid-base status, hemoglobin, and lactate.
Data processing and statistical analyses
Continuous variables are presented as mean ± standard deviation or median (range). Categorical variables are presented as percentages (%) and counts. Two-group comparisons of continuous variables were performed by Student's t-tests if normally distributed or with Wilcoxon rank-sum tests if the normality assumption was violated according to Shapiro-Wilk tests or visual inspection of normal probability plots.
Categorical variables were compared by 2 tests. EP data (AERP, 
RESULTS
The experimental protocol was completed in nine of the 10 animals. 
Hemodynamics
Mean aortic pressure remained unchanged throughout the protocol. In parallel, heart rate and cardiac output decreased with decreasing body core temperature. Mean pulmonary arterial pressure was increased during MH as compared to HT and NT (Table 1) .
Electrophysiologic study
From HT to MH, right atrial effective refractory periods measured by S1-S2 protocols at cycle lengths of 400 and 300 ms increased progressively (S1 400/300 ms: HT 158 ± 36/163 ± 49 ms; NT: Mean ventricular heart rates during AF decreased with decreasing temperature (HT: 180 ± 33 beats/min; NT: 136 ± 22 beats/min; MH: 105 ± 26 beats/min; P < 0.01).
TA B L E 1 Systemic hemodynamics during hyperthermia (HT), normothermia (NT), and mild hypothermia (MH) n = 9 H T N T M H
Temperature ( Mean pulmonary arterial pressure (mm Hg) 17 ± 1.5 18 ± 1.9 21 ± 2.9* , ** Note: * P < 0.05 vs. HT. ** P < 0.05 vs. NT.
F I G U R E 2
In vivo EP study during HT, NT, and MH. A, AERP measured in the right atrium at S1 cycle lengths 300 and 400 ms is prolonged during MH as compared to HT and NT (asterisk indicates P < 0.05 in groupwise comparison for MH vs HT and NT). B, During 50-ms burst pacing, AF is more inducible during MS as compared to HT and NT (asterisk indicates P < 0.05 in groupwise comparison for MH vs HT and NT). Error bars indicate SEM. AERP = atrial effective refractory period; AF = atrial fibrillation; EP = electrophysiology; HT = hyperthermia; MH = mild hypothermia; NT = normothermia; SEM = standard error of the mean F I G U R E 3 Electrocardiographic changes during HT, NT, and MH. A, Stim-Q interval during pacing at rates of 100, 120, and 140 beats/min is prolonged during MH as compared to HT and NT (asterisk indicates P < 0.05 in groupwise comparison for MH vs HT and NT). B, QRS duration remains unchanged between the three temperature steps (P = n.s. in groupwise comparison). C, QT interval is increased with decreasing temperature (asterisk indicates P < 0.05 between all groups). Error bars indicate ± SEM. HT = hyperthermia; MH = mild hypothermia; NT = normothermia; SEM = standard error of the mean
ECG parameters
During spontaneous heart rate, PQ intervals were significantly longer in MH than in HT and NT (HT: 116 ± 17 ms, NT: 131 ± 11 ms, MH: 158 ± 24 ms; P < 0.05). During pacing at 100, 120, and 140 beats/min, Stim-Q intervals were longer with decreasing temperatures but did not differ between different pacing rates (Figure 3a) . QRS duration at spontaneous heart rates was longer during MH as compared to NT (HT: 57 ± 7 ms; NT: 52 ± 8 ms; MH: 64 ± 12 ms; P < 0.05 MH vs NT + HT).
QRS duration remained unchanged throughout the pacing protocol (Figure 3b ). QTc during spontaneous heart rate increased significantly with decreasing temperature (HT: 334 ± 18 ms; NT: 390 ± 28 ms; MH: 599 ± 56 ms; P < 0.05 between all groups). QT duration during pacing was significantly prolonged with each temperature step and shorter with increased pacing rates (Figure 3c ).
TpTe did not differ significantly at spontaneous heart rate (HT: 
Blood gases
Arterial potassium concentration decreased with decreasing body temperature (HT: 4.2 ± 0.1 mmol/L; NT: 4.0 ± 0.2 mmol/L; MH: 3.5 ± 0.1 mmol/L; P < 0.05 between all groups). Hemoglobin, arterial pH levels, lactate, and base excess remained in a normal range during the experimental protocol.
DISCUSSION
While MH is currently tested in multiple other clinical settings besides after resuscitation (clinical trials NCT01069146, NCT01455116, NCT02664194, NCT01890317), possible proarrhythmic effects remain unclear. We sought to test whether cooling per se represents a substrate for increased susceptibility toward AF. For this purpose, we conducted electrophysiological studies in vivo in closed-chest anesthetized pigs. We could prove increased susceptibility to AF during MH compared to NT and HT.
Hypothermia decreases the rate of metabolism, which reduces the rate of depolarization of pacemaker cells. 20 Conduction slowing occurs due to changes in axial resistance as well as prolonged action potential duration (APD) mediated by temperature-dependency of calcium channels leading to increased intracellular calcium. [21] [22] [23] Reduced heart rate in sinus rhythm as well as in AF with decreasing temperatures, prolongation in QT intervals, as well as conduction slowing (prolongation of PQ and Stim-Q intervals) were confirmed in our in vivo setting.
Prolongation of QT intervals during hypothermia is a consistent finding throughout the literature. However, as prolonged QT intervals do not predict ventricular tachyarrhythmias, measuring the TpTe interval was proposed as a marker for repolarization dispersion associated with an increased incidence of ventricular tachyarrhythmias. 17, 18, 24 In the present study, neither changes in TpTe intervals nor spontaneous ventricular tachyarrhythmias were observed.
Studies in ventricular tissue have proposed various possible arrhythmogenic mechanisms. Nonuniform temperatures within the heart during hypothermia may result in dispersion of conduction representing an arrhythmogenic substrate. 25, 26 Transmurally recorded action potentials in canine right ventricular preparations showed that prolongation and dispersion of APD promoted spontaneous premature ventricular activations (PVAs). 21 Optical mapping of canine ventricular wedge preparations confirmed a direct temperature-dependent change of dispersion of repolarization, and this was proposed as a central mechanism of arrhythmogenicity in hypothermia. 27 In accordance with these findings, hypothermia of 30 • C increased the vulnerability to pacing-induced ventricular fibrillation by facilitating wave breaks and promoting the onset of ADP alternans in Langendorff-perfused isolated rabbit hearts. 28 The increased incidence of ventricular fibrillation, which is frequently observed in patients suffering from accidental hypothermia, [29] [30] [31] [32] [33] was also experimentally confirmed in vivo in a porcine model. 34 It was unclear whether MH also presents a substrate for atrial arrhythmogenicity or AF apart from an underlying cardiac disease. Therefore, we assessed the inducibility of AF in anesthetized healthy animals at different temperature levels. We demonstrate that AF is more likely to be induced during MH as compared to NT or HT in healthy pigs. This demonstrates that hypothermia per se represents an arrhythmic substrate, independently of an underlying disease. Interestingly, this arrhythmic substrate is present despite increased atrial refractory periods during hypothermia. Shortening of AERP is attributed to an increased stability of AF, which is well described as electrical remodeling during the progression of AF. 35, 36 On the other hand, therapeutic agents prolonging APD and hence the AERP are used for cardioversion of patients. 37 In the setting of hypothermia, a prolonged AERP seems not to protect the atria from sustaining AF induced by burst pacing. A possible underlying mechanism may be an increased dispersion of repolarization during hypothermia that could be demonstrated during severe (26 • C) as well as during MH (36 • C) in ventricular tissue in prior studies. 27 Although arterial potassium levels decreased during cooling as observed in clinical routine, 38 potassium levels in this study were still within a normal range during hypothermia. In prior clinical studies, an increased incidence of ventricular arrhythmias was associated with much lower potassium levels (< 2.5 mmol/L). 39 While induction of MH resulted in enhanced atrial arrhythmogenicity in this study, HT did not alter AERPs or susceptibility to AF. This is in accordance with multiple preclinical studies that proposed heat shock proteins as a possible therapeutic target to prevent the development of AF. 13, 14 
LIMITATIONS
Due to the experimental setup, the electrophysiological study was limited to the right atrium. Further studies focusing on both atria and more extensive mapping would be necessary to elucidate mechanisms underlying the observed arrhythmic substrate.
We performed our experiments in healthy pigs without cardiac disease. Although the pig heart's anatomy is similar to the human's, there are some minor differences in electrophysiology: Resting heart rate is higher in pigs, while PR and QT intervals are shorter. 40 Pig hearts have been used as a model to study parasympathetic cardiac innervation, but there are some differences in autonomic innervation of porcine and human hearts. 41 There are differences in innervation of the atrioventricular node, atrial, and ventricular tissue. 42 A higher density of parasympathetic nerves within porcine hearts which may contribute to atrial arrhythmogenicity. 43 Since inducibility of AF is infrequent at NT in pigs, we speculate that differences in innervation between the porcine and human heart do not significantly contribute to increased arrhythmogenicity during hypothermia.
Serum potassium levels were within a normal range, but levels decreased with decreasing temperature. Although this effect is known from clinical experience, it also affects atrial arrhythmogenicity.
Since rewarming animals with the intravascular cooling device takes more than twice as long as cooling, order of the temperature steps could not be randomized, since this would have significantly increased experiment duration in some subjects.
CONCLUSION
MH (33 • C) renders atria more susceptible to developing AF during burst protocols in healthy anesthetized pigs although other electrophysiological changes like prolongation of the atrial refractory periods would suggest the opposite. One of the underlying mechanisms may be heterogeneity of conduction.
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